None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients who will agree for giving consent after making aware of the merits/demerits of the trial. 2 Patient full fil at least one criteria for dyslipidemia as explain in diagnostic criteria 3 Patient Agreed for investigations (if needed) before inclusion into the trial and after completion of trial and follow up for assessment and clinical evaluation. Patient full fill at least one criteria for Dyslipidemia as explain in diagnostic criteria
Exclusion criteria
Exclusion criteria: 1 Participants suffering from major systemic disorders like cardiac diseases (IHD), IDDM, uncontrolled Hypertension, Hyperthyroid, Renal and Hepatic diseases etc 2 Not agreed for giving consent / investigations / follow up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome will be assessed by comparing the change from baseline to end of treatment between the Tryushnadi Guggulu and the Atorvastatin.Timepoint: 60 days | — |
Secondary
| Measure | Time frame |
|---|---|
| NillTimepoint: Nill | — |
Countries
India
Contacts
Faculty of Indian Medical System SGT University Gurugram Haryana